Description of Collaborative Activity: |
The overarching workgroup effort is to enhance research initiatives/resource development as IAA workgroup members committed to sustain and accelerate translatability of validation analytics and reference datasets using omic and other multi-omic substitutable [SMART] tools, devices, and HL-7 FHIR technologies to support rapid and efficient interoperability with electronic health records and clinical decision support systems. A second goal is to coordinate and plan trans-NIH and Inter-agency meetings, workshops and initiatives with greater efficiency of ICO resources and expertise between agencies. Innovative technologies like HL-7 SMART on FHIR have been demonstrated to enhance health information exchange, affordably and accurately. Novel device monitoring using reference standards including, FDA Precision and NIST nanofabrication, multi-omics and modeling strategies can be integrated to improve validation and standards biosafety, risk monitoring of adverse drug events, food safety, overuse and resistance to antibiotics, and emerging infection. The intent originated in April 2016 with an Initiative planning meeting that are now ongoing for IAA partnered PCORI; other IAA collaboratives in progress. |
NIH Participating Institutes/Centers/Office of the Director: |
NCCIH, NCI, NHGRI, NIDA, NLM |
